Gout Disease Treatment Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Gout Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gout Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gout Disease Treatment Overall Market Size
2.1 Global Gout Disease Treatment Market Size: 2021 VS 2027
2.2 Global Gout Disease Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gout Disease Treatment Players in Global Market
3.2 Top Global Gout Disease Treatment Companies Ranked by Revenue
3.3 Global Gout Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Gout Disease Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gout Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gout Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Gout Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Gout Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gout Disease Treatment Market Size Markets, 2021 & 2027
4.1.2 Acute Gout
4.1.3 Chronic Gout
4.2 By Type - Global Gout Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Gout Disease Treatment Revenue, 2016-2021
4.2.2 By Type - Global Gout Disease Treatment Revenue, 2022-2027
4.2.3 By Type - Global Gout Disease Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gout Disease Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Homecare Settings
5.1.5 Others
5.2 By Application - Global Gout Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Gout Disease Treatment Revenue, 2016-2021
5.2.2 By Application - Global Gout Disease Treatment Revenue, 2022-2027
5.2.3 By Application - Global Gout Disease Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Gout Disease Treatment Market Size, 2021 & 2027
6.2 By Region - Global Gout Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Gout Disease Treatment Revenue, 2016-2021
6.2.2 By Region - Global Gout Disease Treatment Revenue, 2022-2027
6.2.3 By Region - Global Gout Disease Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Gout Disease Treatment Revenue, 2016-2027
6.3.2 US Gout Disease Treatment Market Size, 2016-2027
6.3.3 Canada Gout Disease Treatment Market Size, 2016-2027
6.3.4 Mexico Gout Disease Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Gout Disease Treatment Revenue, 2016-2027
6.4.2 Germany Gout Disease Treatment Market Size, 2016-2027
6.4.3 France Gout Disease Treatment Market Size, 2016-2027
6.4.4 U.K. Gout Disease Treatment Market Size, 2016-2027
6.4.5 Italy Gout Disease Treatment Market Size, 2016-2027
6.4.6 Russia Gout Disease Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Gout Disease Treatment Market Size, 2016-2027
6.4.8 Benelux Gout Disease Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Gout Disease Treatment Revenue, 2016-2027
6.5.2 China Gout Disease Treatment Market Size, 2016-2027
6.5.3 Japan Gout Disease Treatment Market Size, 2016-2027
6.5.4 South Korea Gout Disease Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Gout Disease Treatment Market Size, 2016-2027
6.5.6 India Gout Disease Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Gout Disease Treatment Revenue, 2016-2027
6.6.2 Brazil Gout Disease Treatment Market Size, 2016-2027
6.6.3 Argentina Gout Disease Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gout Disease Treatment Revenue, 2016-2027
6.7.2 Turkey Gout Disease Treatment Market Size, 2016-2027
6.7.3 Israel Gout Disease Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Gout Disease Treatment Market Size, 2016-2027
6.7.5 UAE Gout Disease Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Takeda Pharmaceutical
7.1.1 Takeda Pharmaceutical Corporate Summary
7.1.2 Takeda Pharmaceutical Business Overview
7.1.3 Takeda Pharmaceutical Gout Disease Treatment Major Product Offerings
7.1.4 Takeda Pharmaceutical Gout Disease Treatment Revenue in Global (2016-2021)
7.1.5 Takeda Pharmaceutical Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gout Disease Treatment Major Product Offerings
7.2.4 Novartis Gout Disease Treatment Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Savient Pharmaceuticals
7.3.1 Savient Pharmaceuticals Corporate Summary
7.3.2 Savient Pharmaceuticals Business Overview
7.3.3 Savient Pharmaceuticals Gout Disease Treatment Major Product Offerings
7.3.4 Savient Pharmaceuticals Gout Disease Treatment Revenue in Global (2016-2021)
7.3.5 Savient Pharmaceuticals Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Gout Disease Treatment Major Product Offerings
7.4.4 AstraZeneca Gout Disease Treatment Revenue in Global (2016-2021)
7.4.5 AstraZeneca Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Gout Disease Treatment Major Product Offerings
7.5.4 GlaxoSmithKline Gout Disease Treatment Revenue in Global (2016-2021)
7.5.5 GlaxoSmithKline Key News
7.6 Merck& Co
7.6.1 Merck& Co Corporate Summary
7.6.2 Merck& Co Business Overview
7.6.3 Merck& Co Gout Disease Treatment Major Product Offerings
7.6.4 Merck& Co Gout Disease Treatment Revenue in Global (2016-2021)
7.6.5 Merck& Co Key News
7.7 Teijin Pharma
7.7.1 Teijin Pharma Corporate Summary
7.7.2 Teijin Pharma Business Overview
7.7.3 Teijin Pharma Gout Disease Treatment Major Product Offerings
7.4.4 Teijin Pharma Gout Disease Treatment Revenue in Global (2016-2021)
7.7.5 Teijin Pharma Key News
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Corporate Summary
7.8.2 Regeneron Pharmaceuticals Business Overview
7.8.3 Regeneron Pharmaceuticals Gout Disease Treatment Major Product Offerings
7.8.4 Regeneron Pharmaceuticals Gout Disease Treatment Revenue in Global (2016-2021)
7.8.5 Regeneron Pharmaceuticals Key News
7.9 Polaris
7.9.1 Polaris Corporate Summary
7.9.2 Polaris Business Overview
7.9.3 Polaris Gout Disease Treatment Major Product Offerings
7.9.4 Polaris Gout Disease Treatment Revenue in Global (2016-2021)
7.9.5 Polaris Key News
7.10 BioCryst Pharmaceuticals
7.10.1 BioCryst Pharmaceuticals Corporate Summary
7.10.2 BioCryst Pharmaceuticals Business Overview
7.10.3 BioCryst Pharmaceuticals Gout Disease Treatment Major Product Offerings
7.10.4 BioCryst Pharmaceuticals Gout Disease Treatment Revenue in Global (2016-2021)
7.10.5 BioCryst Pharmaceuticals Key News
7.11 Nippon Chemiphar
7.11.1 Nippon Chemiphar Corporate Summary
7.11.2 Nippon Chemiphar Business Overview
7.11.3 Nippon Chemiphar Gout Disease Treatment Major Product Offerings
7.11.4 Nippon Chemiphar Gout Disease Treatment Revenue in Global (2016-2021)
7.11.5 Nippon Chemiphar Key News
7.12 JW Pharmaceutical
7.12.1 JW Pharmaceutical Corporate Summary
7.12.2 JW Pharmaceutical Business Overview
7.12.3 JW Pharmaceutical Gout Disease Treatment Major Product Offerings
7.12.4 JW Pharmaceutical Gout Disease Treatment Revenue in Global (2016-2021)
7.12.5 JW Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Gout Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Gout Disease Treatment Market Drivers in Global Market
Table 3. Gout Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Gout Disease Treatment in Global Market
Table 5. Top Gout Disease Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gout Disease Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gout Disease Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gout Disease Treatment Product Type
Table 9. List of Global Tier 1 Gout Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gout Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Gout Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gout Disease Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gout Disease Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Gout Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gout Disease Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gout Disease Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Gout Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gout Disease Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gout Disease Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gout Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gout Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gout Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gout Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gout Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gout Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gout Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gout Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gout Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gout Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Takeda Pharmaceutical Corporate Summary
Table 31. Takeda Pharmaceutical Gout Disease Treatment Product Offerings
Table 32. Takeda Pharmaceutical Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Gout Disease Treatment Product Offerings
Table 35. Novartis Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Savient Pharmaceuticals Corporate Summary
Table 37. Savient Pharmaceuticals Gout Disease Treatment Product Offerings
Table 38. Savient Pharmaceuticals Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Gout Disease Treatment Product Offerings
Table 41. AstraZeneca Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Gout Disease Treatment Product Offerings
Table 44. GlaxoSmithKline Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Merck& Co Corporate Summary
Table 46. Merck& Co Gout Disease Treatment Product Offerings
Table 47. Merck& Co Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Teijin Pharma Corporate Summary
Table 49. Teijin Pharma Gout Disease Treatment Product Offerings
Table 50. Teijin Pharma Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Regeneron Pharmaceuticals Corporate Summary
Table 52. Regeneron Pharmaceuticals Gout Disease Treatment Product Offerings
Table 53. Regeneron Pharmaceuticals Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Polaris Corporate Summary
Table 55. Polaris Gout Disease Treatment Product Offerings
Table 56. Polaris Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 57. BioCryst Pharmaceuticals Corporate Summary
Table 58. BioCryst Pharmaceuticals Gout Disease Treatment Product Offerings
Table 59. BioCryst Pharmaceuticals Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Nippon Chemiphar Corporate Summary
Table 61. Nippon Chemiphar Gout Disease Treatment Product Offerings
Table 62. Nippon Chemiphar Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 63. JW Pharmaceutical Corporate Summary
Table 64. JW Pharmaceutical Gout Disease Treatment Product Offerings
Table 65. JW Pharmaceutical Gout Disease Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Gout Disease Treatment Segment by Type
Figure 2. Gout Disease Treatment Segment by Application
Figure 3. Global Gout Disease Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gout Disease Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gout Disease Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gout Disease Treatment Revenue in 2020
Figure 8. By Type - Global Gout Disease Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gout Disease Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gout Disease Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gout Disease Treatment Revenue Market Share, 2016-2027
Figure 12. US Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gout Disease Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gout Disease Treatment Revenue Market Share, 2016-2027
Figure 24. China Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gout Disease Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gout Disease Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gout Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Takeda Pharmaceutical Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Savient Pharmaceuticals Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. AstraZeneca Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. GlaxoSmithKline Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Merck& Co Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Teijin Pharma Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Regeneron Pharmaceuticals Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Polaris Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. BioCryst Pharmaceuticals Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Nippon Chemiphar Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. JW Pharmaceutical Gout Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Takeda Pharmaceutical
Novartis
Savient Pharmaceuticals
AstraZeneca
GlaxoSmithKline
Merck& Co
Teijin Pharma
Regeneron Pharmaceuticals
Polaris
BioCryst Pharmaceuticals
Nippon Chemiphar
JW Pharmaceutical